N-(2,4-dimethylphenyl)-3-(methylaminomethyl)-1-[3-(trifluoromethyl)phenyl]sulfonylindol-6-amine
C25H24F3N3O2S — CID 122449426
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2,4-dimethylphenyl)-3-(methylaminomethyl)-1-[3-(trifluoromethyl)phenyl]sulfonylindol-6-amine
N-(2,4-dimethylphenyl)-3-(methylaminomethyl)-1-[3-(trifluoromethyl)phenyl]sulfonylindol-6-amine (PubChem CID 122449426) has the molecular formula C25H24F3N3O2S and a molecular weight of 487.55 g/mol. Its IUPAC name is N-(2,4-dimethylphenyl)-3-(methylaminomethyl)-1-[3-(trifluoromethyl)phenyl]sulfonylindol-6-amine.
Molecular Properties
| Compound Name | N-(2,4-dimethylphenyl)-3-(methylaminomethyl)-1-[3-(trifluoromethyl)phenyl]sulfonylindol-6-amine |
|---|---|
| PubChem CID | 122449426 |
| Molecular Formula | C25H24F3N3O2S |
| Molecular Weight | 487.55 g/mol |
| Exact Mass | 487.15 |
| IUPAC Name | N-(2,4-dimethylphenyl)-3-(methylaminomethyl)-1-[3-(trifluoromethyl)phenyl]sulfonylindol-6-amine |
| SMILES | CNCc1cn(S(=O)(=O)c2cccc(C(F)(F)F)c2)c2cc(Nc3ccc(C)cc3C)ccc12 |
| InChI | InChI=1S/C25H24F3N3O2S/c1-16-7-10-23(17(2)11-16)30-20-8-9-22-18(14-29-3)15-31(24(22)13-20)34(32,33)21-6-4-5-19(12-21)25(26,27)28/h4-13,15,29-30H,14H2,1-3H3 |
| InChIKey | FCVMXUFQQQMQBV-UHFFFAOYSA-N |
| XLogP | 5.98 |
| TPSA | 63.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 487.55 |
| LogP ≤ 5 | 5.98 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122449426 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.